Dukes Iain D.
CIK: 0001681955•Chief Executive Officer
OfficerDirector
Primary company: IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Dukes Iain D. is a corporate insider (Chief Executive Officer) at IOVANCE BIOTHERAPEUTICS, INC. (IOVA) filing SEC Form 4 transactions. 43 transactions across 5 companies, totaling $457,596 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 274,000 | $0.68 | $186K | 274,000 | 7/9/2026 Filed: 7/9/2026 | Filing → | |
| Award | 180,632 | - | - | 180,632 | 6/16/2026 Filed: 6/16/2026 | Filing → | |
| Award | 147,771 | - | - | 147,771 | 12/12/2025 Filed: 12/16/2025 | Filing → | |
| Award | 36,943 | - | - | 171,130 | 12/12/2025 Filed: 12/16/2025 | Filing → | |
| Award | 64,839 | - | - | 64,839 | 10/12/2025 Filed: 10/15/2025 | Filing → | |
| Award | 135,092 | - | - | 135,092 | 6/13/2025 Filed: 6/17/2025 | Filing → | |
Lomond Therapeutics Holdings, Inc. NONE | Award | 2,096,667 | - | - | 2,096,667 | 11/1/2024 Filed: 11/5/2024 | Filing → |
| Award | 67,500 | - | - | 134,187 | 4/1/2024 Filed: 8/7/2024 | Filing → | |
| Award | 98,607 | - | - | 98,607 | 6/11/2024 Filed: 6/13/2024 | Filing → | |
Ikena Oncology, Inc. IKNA | Award | 17,520 | - | - | 17,520 | 6/7/2024 Filed: 6/10/2024 | Filing → |
| Award | 4,801 | - | - | 4,801 | 4/1/2024 Filed: 4/3/2024 | Filing → | |
| Award | 194 | - | - | 194 | 4/1/2024 Filed: 4/3/2024 | Filing → | |
| Award | 3,802,890 | - | - | 3,802,890 | 4/1/2024 Filed: 4/3/2024 | Filing → | |
| Award | 1,645,100 | - | - | 1,645,100 | 4/1/2024 Filed: 4/3/2024 | Filing → | |
| Award | 67,550 | - | - | 134,187 | 4/1/2024 Filed: 4/3/2024 | Filing → | |
| Award | 66,687 | - | - | 66,687 | 4/1/2024 Filed: 4/3/2024 | Filing → | |
| Award | 100,000 | - | - | 100,000 | 3/1/2024 Filed: 3/5/2024 | Filing → | |
| Purchase | 32,000 | $9.15 | $293K | 54,000 | 2/20/2024 Filed: 2/20/2024 | Filing → | |
Theseus Pharmaceuticals, Inc. THRX | Disposition | 61,549 | - | - | 0 | 2/14/2024 Filed: 2/14/2024 | Filing → |
Theseus Pharmaceuticals, Inc. THRX | Disposition | 36,066 | - | - | 0 | 2/14/2024 Filed: 2/14/2024 | Filing → |
Type
Award
Shares
274,000
Price
$0.68
Value
$186K
Type
Award
Shares
180,632
Price
-
Value
-
Type
Award
Shares
147,771
Price
-
Value
-
Type
Award
Shares
36,943
Price
-
Value
-
Type
Award
Shares
64,839
Price
-
Value
-
Type
Award
Shares
135,092
Price
-
Value
-
Lomond Therapeutics Holdings, Inc.
NONE
Type
Award
Shares
2,096,667
Price
-
Value
-
Type
Award
Shares
67,500
Price
-
Value
-
Type
Award
Shares
98,607
Price
-
Value
-
Ikena Oncology, Inc.
IKNA
Type
Award
Shares
17,520
Price
-
Value
-
Type
Award
Shares
4,801
Price
-
Value
-
Type
Award
Shares
194
Price
-
Value
-
Type
Award
Shares
3,802,890
Price
-
Value
-
Type
Award
Shares
1,645,100
Price
-
Value
-
Type
Award
Shares
67,550
Price
-
Value
-
Type
Award
Shares
66,687
Price
-
Value
-
Type
Award
Shares
100,000
Price
-
Value
-
Type
Purchase
Shares
32,000
Price
$9.15
Value
$293K
Theseus Pharmaceuticals, Inc.
THRX
Type
Disposition
Shares
61,549
Price
-
Value
-
Theseus Pharmaceuticals, Inc.
THRX
Type
Disposition
Shares
36,066
Price
-
Value
-
AI Agent
Try asking...